or a pharmaceutically acceptable salt, prodrug, or salt of a prodrug thereof, wherein A1, A2, A3, A4, R7, R8, R9, X, Y, Z, L, n, and m, are as defined herein, and are useful in disorders prevented or ameliorated by inhibiting the VR1 receptor."/>
公开/公告号US8440691B2
专利类型
公开/公告日2013-05-14
原文格式PDF
申请/专利权人 ARTHUR GOMTSYAN;EROL K. BAYBURT;ROBERT G. SCHMIDT JR.;CHIH-HUNG LEE;BRIAN S. BROWN;TAMMIE K. JINKERSON;JOHN R. KOENIG;JEROME F. DAANEN;STEVEN P. LATSHAW;
申请/专利号US20100875839
发明设计人 ARTHUR GOMTSYAN;EROL K. BAYBURT;ROBERT G. SCHMIDT JR.;CHIH-HUNG LEE;BRIAN S. BROWN;TAMMIE K. JINKERSON;JOHN R. KOENIG;JEROME F. DAANEN;STEVEN P. LATSHAW;
申请日2010-09-03
分类号A61K31/47;A61K31/445;A61K31/415;C07D217;C07D215;C07D211;C07D231/56;
国家 US
入库时间 2022-08-21 16:46:26